SPS
TYRA icon

Susquehanna Portfolio Strategies’s Tyra Biosciences TYRA Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Sell
47,025
-1,619
-3% -$52.4K 0.03% 514
2025
Q4 		$1.28M Hold
48,644
– – 0.02% 596
2025
Q3 		$681K Hold
48,644
– – 0.01% 757
2025
Q2 		$466K Buy
+48,644
New +$462K 0.01% 669

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Susquehanna Portfolio Strategies's TYRA Position: Q1 2026 in Review

Susquehanna Portfolio Strategies reduced its Tyra Biosciences (TYRA) stake by 3.3% in Q1 2026, selling an estimated $52.4K and leaving 47,025 shares worth $1.8M. The position accounts for 0.03% of the portfolio, ranked #514.

Susquehanna Portfolio Strategies first reported a position in TYRA in Q2 2025 and has held it in 4 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Susquehanna Portfolio Strategies held 47,025 shares of Tyra Biosciences worth $1.8M as of Q1 2026.
  • Susquehanna Portfolio Strategies sold 1,619 Tyra Biosciences shares in Q1 2026, an estimated $52.4K.
  • Tyra Biosciences made up 0.03% of Susquehanna Portfolio Strategies's portfolio in Q1 2026, its #514 holding.
  • Susquehanna Portfolio Strategies first reported a position in Tyra Biosciences in Q2 2025 and has held it in 4 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.